humanitarian
Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Jylamvo, methotrexate, Date of authorisation: 29/03/2017, Revision: 16, Status: Authorised
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
10 reports · 2 sources
EMA What Is NewHuman medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 6, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 6, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 27, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 27, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Zilbrysq, zilucoplan, Date of authorisation: 01/12/2023, Revision: 6, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Zilbrysq, zilucoplan, Date of authorisation: 01/12/2023, Revision: 6, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Zercepac, trastuzumab, Date of authorisation: 27/07/2020, Revision: 16, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Zercepac, trastuzumab, Date of authorisation: 27/07/2020, Revision: 16, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Colchicine Agepha Pharma, colchicine, Date of authorisation: 24/07/2026, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Colchicine Agepha Pharma, colchicine, Date of authorisation: 24/07/2026, Status: Authorised4 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Signal first indexedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources